Richard Malamut, Director at Chromocell Therapeutics Corp (CHRO), bought 10,400 shares at $0.94 ($10K) on 2024-09-12, disclosed to the SEC on 2024-09-16.
Open-market purchase of $10k CHRO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.